| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.38 | 0.03 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.73 | 0.03 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.03 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |